Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
52°
Rain
Toggle navigation
Menu
Subscribe
Home
News
Local News
Sports
Entertainment
Obituaries
Photos
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Rigel Pharmaceuticals
(NQ:
RIGL
)
3.540
USD
UNCHANGED
Streaming Delayed Price
Updated: 7:47 PM EST, Jan 26, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Rigel Pharmaceuticals
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Rigel Pharmaceuticals Provides Business Update
January 11, 2021
TAVALISSE® preliminary 2020 net product sales of approximately $61.7 million, a year-over-year increase of 41%
From
PR Newswire
Rigel to Present at the 39th Annual J.P. Morgan Healthcare Conference
January 07, 2021
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Raul Rodriguez, the company's president and chief executive officer, is scheduled to present a company overview at the 39th Annual J.P....
From
PR Newswire
Global Sarcoma Drugs Market Size Could Reach $1.2 Billion By 2023
December 17, 2020
Tags
Featured News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Global Sarcoma Drugs Market Size Could Reach $1.2 Billion By 2023
December 17, 2020
Financialnewsmedia.com News Commentary
From
PR Newswire
Rigel Announces Two Posters Highlighting TAVALISSE at the 62nd ASH Annual Meeting & Exposition
December 04, 2020
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that data related to TAVALISSE® (fostamatinib disodium hexahydrate) tablets will be presented in two poster presentations at the 62nd American...
From
PR Newswire
Rigel and Medison Announce Health Canada Approval of TAVALISSE®, an Oral Medication for the Treatment of Adults with Chronic Immune Thrombocytopenia
November 23, 2020
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) and Medison Pharma (Medison) today announced that Health Canada has approved the new drug submission (NDS) for TAVALISSE® (fostamatinib disodium hexahydrate)...
From
PR Newswire
Rigel Finalizes the Study Design of its Ongoing Phase 3 Clinical Trial of Fostamatinib in Warm Autoimmune Hemolytic Anemia
November 17, 2020
FDA agrees to the proposed primary efficacy endpoint and additional secondary endpoints
From
PR Newswire
Rigel to Present at the Jefferies Virtual London Healthcare Conference
November 10, 2020
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Raul Rodriguez, the company's president and chief executive officer, is scheduled to present a company overview at the Jefferies Virtual...
From
PR Newswire
Rigel Reports Third Quarter 2020 Financial Results and Provides Business Update
November 05, 2020
Third quarter total revenues of $18.4 million
From
PR Newswire
Rigel Announces Conference Call and Webcast to Report Third Quarter 2020 Financial Results and Business Update
October 29, 2020
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will report its third quarter 2020 financial results after market close on Thursday, November 5, 2020. Rigel senior management will...
From
PR Newswire
Thinking about buying stock in Just Energy, Extreme Networks, Aurora Cannabis, AcelRx Pharmaceuticals, or Rigel Pharmaceuticals?
October 09, 2020
InvestorsObserver issues critical PriceWatch Alerts for JE, EXTR, ACB, ACRX, and RIGL.
From
PR Newswire
Rigel Announces First Patients Enrolled in NIH/NHLBI-Sponsored Trial of Fostamatinib in Hospitalized COVID-19 Patients in Collaboration with Inova
October 09, 2020
Trial being conducted at NIH Clinical Center in Bethesda, Maryland and Inova Fairfax Hospital in Virginia
From
PR Newswire
Thinking about buying stock in Northern Dynasty Minerals, Checkpoint Therapeutics, Rigel Pharmaceuticals, Vaxart, or Aytu Bioscience?
September 17, 2020
InvestorsObserver issues critical PriceWatch Alerts for NAK, CKPT, RIGL, VXRT, and AYTU.
From
PR Newswire
Rigel Announces NIH/NHLBI-Sponsored Trial of Fostamatinib in Hospitalized COVID-19 Patients in Collaboration with Inova
September 17, 2020
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the start of a multicenter, Phase 2 trial to evaluate the safety of fostamatinib, its oral spleen tyrosine kinase (SYK) inhibitor, for the...
From
PR Newswire
Rigel to Present at Two Upcoming Investor Conferences
September 09, 2020
Rigel Pharmaceuticals (Nasdaq: RIGL) today announced that Dean Schorno, the company's chief financial officer, is scheduled to present a company overview at two virtual investor conferences in...
From
PR Newswire
Rigel to Participate in Citi's 15th Annual BioPharma Virtual Conference
September 02, 2020
Rigel Pharmaceuticals (Nasdaq: RIGL) today announced that Raul Rodriguez, the company's president and chief executive officer, is scheduled to participate in a panel discussion on COVID-19 during...
From
PR Newswire
Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
August 21, 2020
Rigel Pharmaceuticals (Nasdaq: RIGL) today announced that it has granted awards pursuant to the Rigel Pharmaceuticals, Inc. Inducement Plan, approved by the Compensation Committee of Rigel's Board of...
From
PR Newswire
Rigel Reports Second Quarter 2020 Financial Results, Provides Business Update, and Overviews COVID-19 Program
August 04, 2020
Second quarter net product sales of $15.0 million, a year-over-year increase of 47%
From
PR Newswire
Rigel Announces Conference Call and Webcast to Report Second Quarter 2020 Financial Results and Business Update
July 28, 2020
Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today announced that it will report its second quarter 2020 financial results after market close on Tuesday, August 4, 2020. Rigel senior management will...
From
PR Newswire
Rigel Announces Post-hoc Data Analysis of TAVALISSE® in Adult Patients with Immune Thrombocytopenia Published in the British Journal of Haematology
July 27, 2020
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), today announced that a paper presenting a post-hoc data analysis of TAVALISSE® (fostamatinib disodium hexahydrate) tablets, as well as accompanying...
From
PR Newswire
Thinking about buying stock in Moleculin Biotech, VBI Vaccines, Rigel Pharmaceuticals, Delta Air Lines, or Vivint Solar?
July 15, 2020
InvestorsObserver issues critical PriceWatch Alerts for MBRX, VBIV, RIGL, DAL, and VSLR.
From
PR Newswire
Clinical Trials for Evolving Targeted Therapies Fueling Gains for Brain Tumor Therapeutics Market
July 15, 2020
Tags
Featured News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Clinical Trials for Evolving Targeted Therapies Fueling Gains for Brain Tumor Therapeutics Market
July 15, 2020
Financialnewsmedia.com News Commentary
From
PR Newswire
Rigel Announces Investigator-Sponsored Trial of Fostamatinib in Patients with COVID-19 Pneumonia
July 14, 2020
High content screen identifies fostamatinib as a candidate for repurposing for Acute Lung Injury
From
PR Newswire
Thinking about buying stock in WiMi Hologram Cloud, Benefytt Technologies, Rigel Pharmaceuticals, Aphria Inc, or Delta Air Lines?
July 13, 2020
InvestorsObserver issues critical PriceWatch Alerts for WIMI, BFYT, RIGL, APHA, and DAL.
From
PR Newswire
Rigel Announces Availability of TAVLESSE® (Fostamatinib Disodium Hexahydrate) in Europe
July 09, 2020
TAVLESSE initial launch in Germany and the U.K. by Grifols S.A.
From
PR Newswire
Rigel to Present at the BMO 2020 Prescriptions for Success Healthcare Virtual Conference
June 17, 2020
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Dean Schorno, the company's chief financial officer, is scheduled to present a company overview at the BMO 2020 Prescriptions for Success...
From
PR Newswire
Rigel to Present Poster Highlighting TAVALISSE at the Virtual Edition of the 25th European Hematology Association (EHA) Annual Congress
June 11, 2020
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that data related to TAVALISSE® (fostamatinib disodium hexahydrate) tablets will be highlighted in a presentation at the Virtual Edition of...
From
PR Newswire
Rigel to Present Four Posters Highlighting IRAK1/4 Inhibitor at the EULAR 2020 E-Congress
June 03, 2020
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that data related to R835, the company's investigational IRAK1/4 inhibitor, will be presented in two oral and two poster presentations at the...
From
PR Newswire
Rigel to Present at the Jefferies Virtual Healthcare Conference
May 26, 2020
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Raul Rodriguez, the company's president and chief executive officer, is scheduled to present a company overview at the Jefferies Virtual...
From
PR Newswire
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.